Familial Mediterranean Fever — Research Summary
Printed from RareWays (rareways.com.au) on 10 June 2026
For general awareness only. Not medical advice. Discuss all care options with your healthcare team.
5 Most Recent Research Articles
- 1.
Food-Grade Microbial Fermentation of Coffee Bean: From Improvement of Quality, Health Benefits, and Safety Factor to Its Sustainable Applications.
Lin Huiying et al. — Comprehensive reviews in food science and food safety (1 May 2026)
https://pubmed.ncbi.nlm.nih.gov/41918181/
- 2.
Inflammatory ankle MRI findings in pediatric and young adult patients with familial Mediterranean fever: a comparison with juvenile idiopathic arthritis and chronic nonbacterial osteomyelitis.
Kraus Matan et al. — Skeletal radiology (1 May 2026)
https://pubmed.ncbi.nlm.nih.gov/41639256/
- 3.
Total flavonoids isolated from Fructus Mume (Prunus mume Sieb. et Zucc.) mitigate Parkinson's disease progression by promoting neuronal mitophagy via activation of the CaMKKβ/AMPK signaling pathway.
Wang Chunling et al. — Journal of ethnopharmacology (24 April 2026)
https://pubmed.ncbi.nlm.nih.gov/41564984/
- 4.
Menstruation in adolescents with Familial Mediterranean Fever: attack trigger or dysmenorrhea? A prospective cross-sectional study.
Kaya Feray et al. — Rheumatology (Oxford, England) (3 April 2026)
https://pubmed.ncbi.nlm.nih.gov/41934112/
- 5.
Anti-Inflammatory Effect of miR-197-3p-Loaded Microvesicles in Familial Mediterranean Fever Mouse Model.
Akkaya-Ulum Yeliz Z et al. — Cell biochemistry and function (1 April 2026)
https://pubmed.ncbi.nlm.nih.gov/41928436/
Clinical Trials — Australian Sites
Ask your doctor whether you or your child may be eligible for any of these trials.
- 1.
Safety and Tolerability, Pharmacokinetic and Pharmacodynamic Study With IZD334
Completed — Phase 1 — Inflazome UK Ltd
https://clinicaltrials.gov/study/NCT04086602
- 2.
A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZYIL1 in Subjects With Cryopyrin Associated Periodic Syndromes (CAPS)
Completed — Phase 2 — Zydus Lifesciences Limited
https://clinicaltrials.gov/study/NCT05186051
Source: RareWays research directory. Data from PubMed, Europe PMC, OpenAlex, ClinicalTrials.gov.
Always verify information with your healthcare team before making any decisions about your care.
Familial Mediterranean Fever
Familial Mediterranean Fever is the most common hereditary autoinflammatory disease, caused by mutations in the MEFV gene. It causes recurrent episodes of fever and serositis (painful inflammation of the lining of the abdomen, chest, or joints). It predominantly affects people of Mediterranean and Middle Eastern descent. Colchicine is highly effective in preventing attacks and reducing amyloid risk.
Most Recent Research
The coffee industry is under growing pressure to implement sustainable practices while enhancing product value. Food-grade microbial fermentation (FMF) offers a viable pathway for valorize coffee and its by-products, thereby supporting the sustainable transformation of the coffee sector. This review systematically elaborates on the selection of fermentation microorganisms and their functional properties, evaluates fermentation-induced changes in the nutritional and bioactive constituents of coffee, and elucidates the underlying mechanisms facilitating the transformation and release of these components. Furthermore, the review analyzes the influence of microbial activity on the flavor and aroma profile of coffee and summarizes the health-promoting effects enhanced by fermentation, together with their associated molecular mechanisms. Safety aspects related to FMF are also critically discussed. Accumulating evidence indicates that fermented coffee exhibits a broad spectrum of bioactivities, including antioxidant, antimicrobial, hypolipidemic, antidiabetic, neuroprotective, and anti-inflammatory effects. These properties support its application in the development of functional beverages such as probiotic-enriched and reduced-caffeine coffee products. Additionally, FMF enables the transformation of coffee by-products into high-value products such as functional ingredients, enzymes, and organic acids, offering a viable strategy for waste reduction and economic optimization. The originality of this review lies in its integrative synthesis of recent advances in FMF from the perspectives of coffee quality enhancement, mechanisms of health effects, and safety risk management. By constructing a comprehensive analytical framework of "fermentation regulation-component transformation-functional realization," this review provides clear academic guidance for the future development of fermented coffee in functional foods and sustainable industrial applications.
Common Questions
What is Familial Mediterranean Fever?
Familial Mediterranean Fever is the most common hereditary autoinflammatory disease, caused by mutations in the MEFV gene. It causes recurrent episodes of fever and serositis (painful inflammation of the lining of the abdomen, chest, or joints). It predominantly affects people of Mediterranean and Middle Eastern descent. Colchicine is highly effective in preventing attacks and reducing amyloid risk.
How many clinical trials are available for Familial Mediterranean Fever?
RareWays currently indexes 67 clinical trials for Familial Mediterranean Fever, of which 14 are actively recruiting. Trial availability changes as new studies are registered — check the trials tab for current status.
Where does the research data for Familial Mediterranean Fever come from?
RareWays aggregates research from PubMed, Europe PMC, OpenAlex, and ClinicalTrials.gov. Data is updated regularly by Rocky, RareWays' automated research engine. All articles and trials link directly to their original sources.
Get research updates
Monthly email when new findings are published for Familial Mediterranean Fever.
No spam. Unsubscribe any time. Not medical advice.
This information is for general awareness only.
For guidance specific to your situation, please speak with your healthcare team.